Orchestra BioMed Holdings, Inc. (OBIO)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue | 836 | 868 | 987 | 778 |
| Selling, general and administrative | 6,264 | 6,263 | 5,666 | 6,467 |
| Research and development | 13,853 | 13,482 | 11,595 | 11,126 |
| Cost of product revenues | 46 | 44 | 68 | 44 |
| Total expenses | 20,163 | 19,789 | 17,329 | 17,637 |
| Loss from operations | -19,327 | -18,921 | -16,342 | -16,859 |
| Interest income (expense), net | - | - | - | 902 |
| Gain (loss) on investments | - | - | - | -23 |
| Interest (expense) income, net | -36 | 166 | 916 | - |
| Total other (expense) income | -36 | 166 | 916 | 879 |
| Net loss | -19,363 | -18,755 | -15,426 | -15,980 |
| Unrealized gain (loss) on marketable securities | -21 | -15 | 121 | -15 |
| Comprehensive loss | -19,384 | -18,770 | -15,305 | -15,995 |
| Earnings per share, basic | -0.5 | -0.49 | -0.41 | -0.45 |
| Earnings per share, diluted | -0.5 | -0.49 | -0.41 | -0.45 |
| Weighted average number of shares outstanding, basic | 38,392,716 | 38,235,409 | 37,621,495 | 35,800,273 |
| Weighted average number of shares outstanding, diluted | 38,392,716 | 38,235,409 | 37,621,495 | 35,800,273 |